Literature DB >> 12044283

Clinical implications of antimicrobial resistance: how big is the problem?

Georgia Duckworth1.   

Abstract

This presentation addresses the question of the size of the antimicrobial resistance problem by examining the monitoring of antimicrobial use and resistance. It focuses on the main sources of information, possible pitfalls of the data and the susceptibility of the main pathogens responsible for bacteraemias in England and Wales. It addresses some of the difficulties in establishing the link between antimicrobial resistance and antimicrobial prescribing and concludes with some thoughts on necessary developments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044283     DOI: 10.1016/s1201-9712(02)90148-7

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  2 in total

1.  Comparative in vitro surveillance of amoxicillin-clavulanic acid and four oral comparators against 21232 clinical isolates from europe.

Authors:  D J Hoban; S K Bouchillon; J L Johnson; G G Zhanel; D L Butler; K A Saunders; L A Miller; J A Poupard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-28       Impact factor: 3.267

2.  Coinfection With Influenza A Virus and Klebsiella oxytoca: An Underrecognized Impact on Host Resistance and Tolerance to Pulmonary Infections.

Authors:  Kayla M Lee; Jenna Morris-Love; Damien J Cabral; Peter Belenky; Steven M Opal; Amanda M Jamieson
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.